Press Release

Massachusetts General Hospital Selects VTOC for Multi-Center Prostate Cancer Research Study

February 12, 2016

VisionTree®, a leader in cloud-based, patient reported outcomes, patient engagement and multi-center research/registry solutions, announced today via Twitter that Massachusetts General Hospital has chosen to adopt the VisionTree Optimal Care (VTOC) v5.0 platform as its patient portal to deliver patient-reported quality of life assessments for its multi-center prostate cancer research study across several sites.


About VisionTree®

VisionTree Software, Inc., a Brainlab company, is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The VisionTree Optimal Care (VTOC) outcomes platform is MACRA compliant as a modular EHR and implemented at over 600 sites with 2.5M+ patient records in 15+ languages.

The VTOC platform is used for multi-center research, registries and population health initiatives across multiple domains. VisionTree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 17 of the top 20 U.S. News and World Report hospitals.